This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 Mar;6(3):159.

doi: 10.1038/ncpcardio1454.

JUPITER strikes earth

Valentin Fuster, Sameer Bansilal

PMID: 19234496
DOI: 10.1038/ncpcardio1454

Editorial

JUPITER strikes earth

Valentin Fuster et al. Nat Clin Pract Cardiovasc Med. 2009 Mar.

. 2009 Mar;6(3):159.

doi: 10.1038/ncpcardio1454.

Authors

Valentin Fuster, Sameer Bansilal

PMID: 19234496
DOI: 10.1038/ncpcardio1454

Erratum in

Nat Clin Pract Cardiovasc Med. 2009 May;6(5):326

No abstract available

PubMed Disclaimer

Similar articles

Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
Feeman WE Jr. Feeman WE Jr. Lancet. 2009 Jul 4;374(9683):24; author reply 26-7. doi: 10.1016/S0140-6736(09)61228-9. Lancet. 2009. PMID: 19577687 No abstract available.
The JUPITER Trial: responding to the critics.
Ridker PM, Glynn RJ. Ridker PM, et al. Am J Cardiol. 2010 Nov 1;106(9):1351-6. doi: 10.1016/j.amjcard.2010.08.025. Epub 2010 Sep 21. Am J Cardiol. 2010. PMID: 21029837 No abstract available.
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Macfadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Trial Study Group. Ridker PM, et al. Lancet. 2009 Apr 4;373(9670):1175-82. doi: 10.1016/S0140-6736(09)60447-5. Epub 2009 Mar 28. Lancet. 2009. PMID: 19329177 Clinical Trial.
Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk.
Nicholls SJ, Uno K, Kataoka Y. Nicholls SJ, et al. Expert Rev Cardiovasc Ther. 2011 Nov;9(11):1383-90. doi: 10.1586/erc.11.145. Expert Rev Cardiovasc Ther. 2011. PMID: 22059787 Review.
[Pharmacological and clinical profile of rosuvastatin calcium (Crestor)].
Ohfuji K, Yano S, Yamaguchi M, Smith G, Hirata M, Shimada H, Izuishi K, Shinagawa J, Matsunaga K. Ohfuji K, et al. Nihon Yakurigaku Zasshi. 2005 Sep;126(3):213-9. doi: 10.1254/fpj.126.213. Nihon Yakurigaku Zasshi. 2005. PMID: 16272766 Review. Japanese. No abstract available.

See all similar articles

Cited by

Is Jupiter also a god of primary prevention?
Accad M, Fred HL. Accad M, et al. Tex Heart Inst J. 2010;37(1):6-7. Tex Heart Inst J. 2010. PMID: 20200621 Free PMC article. No abstract available.
Human C-reactive protein does not promote atherosclerosis in transgenic rabbits.
Koike T, Kitajima S, Yu Y, Nishijima K, Zhang J, Ozaki Y, Morimoto M, Watanabe T, Bhakdi S, Asada Y, Chen YE, Fan J. Koike T, et al. Circulation. 2009 Nov 24;120(21):2088-94. doi: 10.1161/CIRCULATIONAHA.109.872796. Epub 2009 Nov 9. Circulation. 2009. PMID: 19901190 Free PMC article.

References

1. N Engl J Med. 2008 Nov 20;359(21):2195-207 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information